# Pharmacokinetics & Metabolism ### The microbiome conversion problem Urolithin A is not supplied directly by food. It must be produced by gut bacteria from ellagitannins and ellagic acid. That creates a major variability problem. Some people appear to generate meaningful levels from diet. Many do not. ### Why direct supplementation matters This is one of the clearest practical advantages of direct Urolithin A supplementation. It bypasses the microbiome-conversion bottleneck and gives more predictable plasma exposure. That matters both for clinical-trial design and for real-world use. ### Absorption and circulation Human pharmacokinetic studies suggest orally administered Urolithin A is well absorbed. It circulates as free compound and as conjugated metabolites. Plasma exposure rises in a dose-dependent way across commonly studied oral doses. ### Tissue distribution One of the more interesting oncology findings is that Urolithin A has been detected in malignant colon tissue after precursor supplementation. That does not prove broad tumour targeting. It does support further interest in colorectal and gastrointestinal settings. ### Stability and metabolism Urolithin A belongs to the wider family of urolithin metabolites. It is the best-studied and most biologically interesting member of that group. Under physiological conditions, it appears reasonably stable. Its handling is still shaped by gut, liver, and conjugation processes. ### Practical implications The pharmacokinetic story supports several practical conclusions: * diet alone is unreliable for consistent exposure * direct supplementation is more predictable * plasma levels do not automatically tell us tumour-site activity in every cancer type * oral dosing questions in active oncology still need more human data ### Bottom line Urolithin A stands out because it has a real pharmacokinetic rationale for direct supplementation. That does not solve every oncology question. It does make this compound easier to study seriously than many microbiome-derived metabolites. ### In this section * [Overview](/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology.md) * [Evidence Summary](/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/evidence-summary.md) * [Anticancer Mechanisms](/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/anticancer-mechanisms.md) * [Immune Effects](/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/immune-effects.md) * [Synergistic Combinations](/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/synergistic-combinations.md) * [Urolithin A Evidence by Cancer Type](/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type.md) * [Pharmacokinetics & Metabolism](/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/pharmacokinetics-and-metabolism.md) * [Safety & Interactions](/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/safety-and-interactions.md) * [Dosing & Timing](/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/dosing-and-timing.md) * [Sourcing Quality Urolithin A](/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/sourcing-quality-urolithin-a.md) * [Sensitisation to Conventional Therapies](/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/sensitisation-to-conventional-therapies.md) * [Antimicrobial, Antiviral & Terrain Support](/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/antimicrobial-antiviral-and-terrain-support.md) ### Key References Human safety, absorption, and plasma exposure of oral Urolithin A\ Urolithin A research overview and oncology applications\ Direct supplementation compared with dietary precursor exposure\ {% hint style="warning" %} This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use. {% endhint %} {% hint style="info" %} © 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text. {% endhint %} --- # Agent Instructions: Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter: ``` GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/pharmacokinetics-and-metabolism.md?ask= ``` The question should be specific, self-contained, and written in natural language. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.